Change search criteria ↓

Search results

1 681 projects found matching your search criteria:

  1. 301. Role of natural products in overcoming drug resistance in Mycobacterium tuberculosis

    Principal investigator: dr Elwira Zofia Sieniawska

    Uniwersytet Medyczny w Lublinie

    Call: OPUS 23, Panel: NZ7

  2. 302. Allosteric and allosteric-orthosteric bitopic ligands of histamine receptor H4 as a way to increase selectivity and bias…

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 23, Panel: NZ7

  3. 303. Modulation of HIV-1 epitranscriptome: A novel approach to improve "shock & kill" therapy.

    Principal investigator: Haider Ali brak danych (PI has only a Name - in accordance with PESEL)

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: PRELUDIUM 21, Panel: NZ6

  4. 304. Understanding drug/polymer/plasticizer miscibility and its effect on mechanical properties of polymeric filaments for FD…

    Principal investigator: Marta Maria Kozakiewicz-Latała

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 21, Panel: NZ7

  5. 305. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi…

    Principal investigator: prof. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 23, Panel: NZ7

  6. 306. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Principal investigator: Karolina Barbara Przepiórska-Drońska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 21, Panel: NZ7

  7. 307. The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud…

    Principal investigator: dr Magdalena Białoń

    Instytut Farmakologii PAN

    Call: PRELUDIUM 21, Panel: NZ7

  8. 308. A comprehensive approach to powders for pharmaceutical 3D printing using Selective Laser Sintering - development of stra…

    Principal investigator: dr hab. Piotr Paweł Kulinowski

    Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie

    Call: OPUS 23, Panel: NZ7

  9. 309. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D…

    Principal investigator: Kinga Maria Czarnota-Łydka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 21, Panel: NZ7

  10. 310. Effects of activation of cholinergic, noradrenergic, and serotonergic systems on respiratory impairment in Alzheimer's d…

    Principal investigator: prof. Katarzyna Kaczyńska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 23, Panel: NZ7

  11. 311. Bioconjugates of 103Pd nanostructures for targeted Auger electron therapy.

    Principal investigator: dr hab. Agnieszka Majkowska-Pilip

    Instytut Chemii i Techniki Jądrowej

    Call: OPUS 23, Panel: ST5

  12. 312. Can keto diet save the brain? The effect of the ketogenic diet on glial scar formation after traumatic brain injury.

    Principal investigator: Zuzanna Maria Rauk

    Uniwersytet Jagielloński, Wydział Biologii

    Call: PRELUDIUM 21, Panel: NZ4

  13. 313. Extracellular vesicles modifications for future drug delivery systems

    Principal investigator: prof. Ewa Łucja Stępień

    Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

    Call: OPUS 23, Panel: NZ7

  14. 314. Modulating effect of elicitors on the biosynthesis of bioactive metabolites in Nigella damascena in vitro cultures - A t…

    Principal investigator: dr Magdalena Klimek-Chodacka

    Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Biotechnologii i Ogrodnictwa

    Call: OPUS 23, Panel: NZ7

  15. 315. Pharmacogenomics of SGLT2 inhibitors - investigating the role of empagliflozin in epigenetic modification of non-coding …

    Principal investigator: Anna Nowak-Szwed

    Warszawski Uniwersytet Medyczny

    Call: PRELUDIUM 21, Panel: NZ7

  16. 316. The application of artificial intelligence to the discovery of new natural drugs with mechanisms aimed at lowering free …

    Principal investigator: Maciej Spiegel

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

    Call: PRELUDIUM 21, Panel: NZ7

  17. 317. EEG/ECoG based functional connectivity neuroimaging in the rat - optimisation, standardisation and translational leap in…

    Principal investigator: prof. Daniel Krzysztof Wójcik

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: WEAVE-UNISONO, Panel: NZ4

  18. 318. The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on changes in selected epigenetic mechan…

    Principal investigator: Agnieszka Magdalena Woźniak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 21, Panel: NZ7

  19. 319. Amino acids among biomarkers for blood pressure level – causal inference using molecular, epidemiological, and genetic a…

    Principal investigator: dr hab. Mateusz Siedliński

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 23, Panel: NZ4

  20. 320. Transgenerational inheritance of Liver Disease in mouse offspring conceived by Assisted Reproduction Technologies.

    Principal investigator: dr Maria Florencia Heber

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: SONATINA 6, Panel: NZ4

  21. 321. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st…

    Principal investigator: dr Bartłomiej Pochwat

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ7

  22. 322. The use of genetic analysis of liquid biopsy for predicting and monitoring ofresponse to therapies and tumor evolution i…

    Principal investigator: dr Magdalena Olbryt

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

    Call: OPUS 22, Panel: NZ7

  23. 323. Characterization of childhood asthma and IgE-dependent allergy asthma endotypes using integrated clinical, metabolomic a…

    Principal investigator: prof. Jan Franciszek Matysiak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM BIS 3, Panel: NZ5

  24. 324. Mechanisms and consequences of small cerebral blod vessels dysfunction inexperimental hyponatremia in the presence of va…

    Principal investigator: dr Marta Aleksandrowicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: SONATA 17, Panel: NZ4

  25. 325. Molecular determinants of input specificity in plasticity phenomena at GABAergic synapses in the hippocampus

    Principal investigator: prof. Jerzy Władysław Mozrzymas

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: OPUS 22, Panel: NZ4

  26. 326. Electrospun nanofiber-based nanoplatform for delivery of new nutraceutical derivatives to eliminate chemotherapy-induced…

    Principal investigator: dr hab. Maciej Antoni Wnuk

    Uniwersytet Rzeszowski, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  27. 327. Cognitive impairment in chronic pain - CBD as the undervalued remedy.

    Principal investigator: prof. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ7

  28. 328. Targeting UDP-glucose and P2Y14 receptor interaction for therapeutic modulation of inflammatory lung diseases

    Principal investigator: dr Tadeusz Piotr Karcz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ7

  29. 329. Biological roles of transcriptional networks activated in the brain by psychotropic drugs

    Principal investigator: dr hab. Michał Korostyński

    Instytut Farmakologii PAN

    Call: PRELUDIUM BIS 3, Panel: NZ7

  30. 330. Perinuclear AKAP6 signalosome as a new target for gene therapy in ischemic optic neuropathy

    Principal investigator: dr hab. Tomasz Boczek

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

    Call: OPUS 22, Panel: NZ4

  31. 331. Involvement of gasotransmitter systems in the brain response to seizure activity in animal models of epilepsy

    Principal investigator: prof. Krzysztof Jan Janeczko

    Uniwersytet Jagielloński, Wydział Biologii

    Call: PRELUDIUM BIS 3, Panel: NZ4

  32. 332. Bifunctional, pH-responsive zeolite-bisphosphonates complex as a base for the production of smart bone implant for osteo…

    Principal investigator: prof. Agata Natalia Przekora-Kuśmierz

    Uniwersytet Medyczny w Lublinie, Wydział Nauk Medycznych

    Call: OPUS 22, Panel: NZ7

  33. 333. Glymphatic system in epilepsy pathogenesis.

    Principal investigator: prof. Katarzyna Łukasiuk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 22, Panel: NZ4

  34. 334. Impact of the CDK4/6 targeted degradation by PROTACs on immune checkpoint signaling in cancer

    Principal investigator: dr Katarzyna Magiera-Mularz

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 22, Panel: NZ7

  35. 335. Novel pathway of vitamin B12 activation by CD73 - analysis of molecular mechanisms, in vivo processing and clinical rele…

    Principal investigator: dr hab. Marta Urszula Tomczyk

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: SONATA 17, Panel: NZ4

  36. 336. Translational and interdisciplinary investigation of phenotypes of reinforcement sensitivity as predictors of the respon…

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: HS6

  37. 337. Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

    Principal investigator: dr Monika Anna Musiał-Kulik

    Centrum Materiałów Polimerowych i Węglowych PAN

    Call: SONATA 17, Panel: NZ7

  38. 338. Novel broad-spectrum central nervous system active substances: optimization of their multi-target profile

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 22, Panel: NZ7

  39. 339. Keap1-dependent proteopathy as a unifying mechanism of vascular dysfunction

    Principal investigator: dr hab. Anna Maria Grochot-Przęczek

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 22, Panel: NZ4

  40. 340. Structure-guided design of histone demethylase inhibitors for cancer therapy.

    Principal investigator: dr Piotr Henryk Małecki

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 17, Panel: NZ7

  41. 341. Development of the knowledge on the role of GPR18 ligands as a microglia-targeted strategy in the regulation of neuroinf…

    Principal investigator: dr Ewelina Barbara Honkisz-Orzechowska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ3

  42. 342. Inhibition of protein disulfide isomerases as a strategy for reduction of prothrombotic state in atherosclerosis; therap…

    Principal investigator: dr Kamil Przyborowski

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: SONATA 17, Panel: NZ7

  43. 343. Multiomic level analyses in atypical diabetes patient derived iPSC and pancreatic cells- key to function

    Principal investigator: dr hab. Maciej Maurycy Łałowski

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: POLONEZ BIS 1, Panel: NZ4

  44. 344. Bleomycin hydrolase, homocysteine metabolism, epigenetic regulation of mTOR signalling, autophagy, and Alzheimer's disea…

    Principal investigator: dr hab. Joanna Perła-Kaján

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Rolnictwa, Ogrodnictwa i Biotechnologii

    Call: OPUS 22, Panel: NZ4

  45. 345. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATA 17, Panel: NZ7

  46. 346. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap…

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 22, Panel: NZ7

  47. 347. Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  48. 348. Species belonging to lichens and bryophytes as a useful source of biologically active compounds in therapy of skin disea…

    Principal investigator: prof. Sławomir Daniel Dresler

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM BIS 3, Panel: NZ7

  49. 349. A new animal model of human McArdle disease in zebrafish (Danio rerio)

    Principal investigator: dr hab. Marta Migocka-Patrzałek

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

    Call: SONATA 17, Panel: NZ4

  50. 350. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ6

Graphic design and implementation: Jakub Piotrowski